Brenntag AG (OTCMKTS:BNTGY – Get Free Report) has received a consensus recommendation of “Reduce” from the nine research firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation and eight have assigned a hold recommendation to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $12.80.
A number of research firms have recently weighed in on BNTGY. Jefferies Financial Group raised Brenntag from a “moderate sell” rating to a “hold” rating in a research report on Wednesday, May 20th. Morgan Stanley reaffirmed an “underweight” rating on shares of Brenntag in a research report on Friday, May 15th. Finally, UBS Group raised Brenntag from a “sell” rating to a “neutral” rating in a research report on Thursday, April 30th.
View Our Latest Stock Analysis on Brenntag
Brenntag Price Performance
Brenntag (OTCMKTS:BNTGY – Get Free Report) last released its earnings results on Wednesday, May 13th. The company reported $0.16 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.02). Brenntag had a return on equity of 5.38% and a net margin of 1.55%.The business had revenue of $4.29 billion for the quarter, compared to analyst estimates of $4.33 billion. On average, equities research analysts anticipate that Brenntag will post 0.8 earnings per share for the current fiscal year.
About Brenntag
Brenntag SE, trading on OTCMKTS as BNTGY, is a global market leader in the distribution of chemicals and ingredients. With headquarters in Essen, Germany, the company serves a wide range of industries including coatings and construction, cleaning and water treatment, food and nutrition, pharmaceuticals and personal care, as well as oil and gas. Brenntag operates through two core segments—Essentials and Specialties—offering both standard commodity chemicals and tailored specialty solutions to customers around the world.
Its product portfolio encompasses inorganic and organic chemicals, polymers, petrochemicals and specialty ingredients.
Featured Articles
- Five stocks we like better than Brenntag
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.
